Featured

Hope for people with sickle cell disease with first treatment in 30 years



Published
The first breakthrough drug in 30 years for people living with sickle cell disease has been announced by drugs firm Novartis.

'Adakveo' is the first targeted therapy for prevention of recurrent crises attacks.

These attacks disrupt patients’ lives physically, socially, and emotionally, and can increase risk of organ damage and early death.

Clinical data showed that use of Adakveo led to a significant reduction in their rate, and to fewer days spent in hospital.

SUBSCRIBE to our YouTube channel for more videos: http://www.youtube.com/skynews

Follow us on Twitter: https://twitter.com/skynews

Like us on Facebook: https://www.facebook.com/skynews

Follow us on Instagram: https://www.instagram.com/skynews

For more content go to http://news.sky.com and download our apps:

Apple: https://itunes.apple.com/gb/app/sky-news/id316391924?mt=8

Android https://play.google.com/store/apps/details?id=com.bskyb.skynews.android&hl=en_GB

Sky News videos are now available in Spanish here/Los video de Sky News están disponibles en español aquí https://www.youtube.com/channel/skynewsespanol
Category
Health
Be the first to comment